An immunometabolic signature of major depressive disorder in systemic lupus erythematosus

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Autoimmune Disease

Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus

Ann Rheum Dis

Parodis I, Iacubino M, Rocco L, Nikolopoulos D, Palazzo L, Grimmett L, Kerr M, Bellocchi C, Vigone B, Santaniello A, Barturen G, Voskuyl AE, Alarcón-Riquelme ME, Beretta L

doi: 10.1016/j.ard.2025.12.005

Systemic Lupus Erythematosus

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

Ann Rheum Dis

Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A, PRECISESADS Clinical Consortium, Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I

doi: 10.1016/j.ard.2025.06.2132

Systemic Lupus Erythematosus

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

Rheumatology (Oxford)

Onishi A, Tsuji H, Sasai T, Shirakashi M, Hiwa R, Nakabo S, Akizuki S, Nakashima R, Nishimura K, Sada KE, Miyawaki Y, Umeda M, Yoshimi R, Ohno S, Yajima N, Kajiyama H, Sato S, Kishida D, Fujiwara M, Kida T, Matsuo Y, Takatani A, Onishi T, Ida T, Umekita K, Miyake H, Nakano H, Ikeda K, Ichinose K, Yoshifuji H, Tanaka M, Morinobu A

doi: 10.1093/rheumatology/keag080

Systemic Lupus Erythematosus

Upper limb function impairment is independently associated with all Lupus Quality of Life (LupusQoL) domains in systemic lupus erythematosus

Rheumatology (Oxford)

Arkoumanis I, Pappa M, Keramiotou K, Sfikakis PP, Tektonidou MG

doi: 10.1093/rheumatology/keag025

Systemic Lupus Erythematosus

Human papillomavirus vaccine uptake in ethnically diverse women living with systemic lupus erythematosus

Lupus

Bruera S, Huang Y, Bowman S, Suarez-Almazor ME, Lo GH, Lopez-Olivo MA, Chiao E, Kramer JR, Pereira FA, Agarwal SK

doi: 10.1177/09612033251390599

Systemic Lupus Erythematosus

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus

N Engl J Med

van Vollenhoven RF, Wang L, Merrill JT, Liu Y, Bao C, Li F, Hu J, Huang C, Zhao J, Huang C, Mo H, Wei W, Lu F, Li J, Zhao D, Wang W, Li L, Zuraw Q, Wang X, Wang X, Fang J, Zhang F, 18C010 Trial Investigators

doi: 10.1056/NEJMoa2414719

Systemic Lupus Erythematosus

Polypharmacy in Adults with Systemic Lupus Erythematosus

Arthritis Care Res (Hoboken)

Yang J, Growdon ME, Fitzpatrick J, Dunlop-Thomas C, Hoge C, Covinsky KE, Bowling CB, Lim SS, Yazdany J, Plantinga LC

doi: 10.1002/acr.25686

Systemic Lupus Erythematosus

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

Semin Arthritis Rheum

Ibarguengoitia-Barrena O, Riancho-Zarrabeitia L, Plaza Z, Rúa-Figueroa Í, Roberts K, Martínez-Taboada V, Menor-Almagro R, Serrano-Benavente B, Rubio-Muñoz P, Galindo-Izquierdo M, Fernández-Nebro A, Ruiz-Lucea ME, Calvo-Alén J, Tomero-Muriel EG, Uriarte-Isacelaya E, Pecondon-Españo A, Freire M, García-Fernández J, Expósito L, Ibañez-Barceló M, Aurrecoechea E, Montilla C, Rosas-Gómez de Salazar J, García-Villanueva MJ, Caño-Alameda R, Toyos-Sáenz de Miera FJ, Nóvoa-Medina FJ, Moriano-Morales C, Bonilla G, Narváez FJ, Andréu JL, Arévalo-Salaet M, Horcada L, Cobo T, Lozano-Rivas N, Bohorquez C, Iñíguez-Ubiaga CL, Salgado-Perez E, Torrente-Segarra V, Salman Monte TC, Oller JE, Pego-Reigosa JM, RELESSER research group

doi: 10.1016/j.semarthrit.2025.152819

Related content

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus

Upper limb function impairment is independently associated with all Lupus Quality of Life (LupusQoL) domains in systemic lupus erythematosus

Human papillomavirus vaccine uptake in ethnically diverse women living with systemic lupus erythematosus

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus

Polypharmacy in Adults with Systemic Lupus Erythematosus

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study